Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
India rejects HIV drug patent
For once no Patents please
India Allows Use of Generic Versions of Abbott AIDS Drug: Biotech’s Latest Tribulations
India rejects unmerited patent application by Abbott for HIV drug
Abbott denied patent for liponavir/ritonavir HIV drug combo in India
India Rejects Patent Application for Abbott’s Kaletra
Abbott’s HIV drug patent plea rejected for lack of novelty
Abbott Laboratories HIV Drug Rejected
India Rejects Abbott patent of Kaletra AIDS drug
India rejects Abbott’s patent application for Kaletra